Planet 13 Holdings Inc
CNSX:PLTH
Planet 13 Holdings Inc
Cost of Revenue
Planet 13 Holdings Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Planet 13 Holdings Inc
CNSX:PLTH
|
Cost of Revenue
-$53.7m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cost of Revenue
-$27.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cost of Revenue
-$11.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
Pfizer Inc
NYSE:PFE
|
Cost of Revenue
-$16.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-6%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cost of Revenue
-$12.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cost of Revenue
-$8.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
|
Planet 13 Holdings Inc
Glance View
Planet 13 Holdings, Inc. engages in the manufacture and production of cannabis products. The company is headquartered in Las Vegas, Nevada and currently employs 575 full-time employees. The company went IPO on 2018-06-21. The firm owns and manufactures cannabis products under various brands, including HaHa (gummies and beverages), Dreamland (chocolates), Trendi (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes). Through its subsidiaries in Nevada, it holds six licenses for cultivation (three medical licenses and three recreational licenses), six licenses for production (three medical licenses and three recreational licenses), three dispensary licenses (one medical license and two recreational licenses) and two distribution licenses (one active and one conditional). The company operates two dispensaries in Nevada under two adult-use and one medical licenses. Its manufactured products and Trendi-branded third-party flower are distributed through Nevada under its Nevada distribution license. The firm sells over 123 different strains of cannabis.
See Also
What is Planet 13 Holdings Inc's Cost of Revenue?
Cost of Revenue
-53.7m
USD
Based on the financial report for Dec 31, 2023, Planet 13 Holdings Inc's Cost of Revenue amounts to -53.7m USD.
What is Planet 13 Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-34%
Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Planet 13 Holdings Inc have been -15% over the past three years , -34% over the past five years .
You don't have any saved screeners yet